Protalix BioTherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLX and other ETFs, options, and stocks.About PLX
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11.
CEODror Bashan
CEODror Bashan
Employees213
Employees213
HeadquartersHackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded1993
Founded1993
Employees213
Employees213
PLX Key Statistics
Market cap146.35M
Market cap146.35M
Price-Earnings ratio25.76
Price-Earnings ratio25.76
Dividend yield—
Dividend yield—
Average volume534.99K
Average volume534.99K
High today$1.86
High today$1.86
Low today$1.77
Low today$1.77
Open price$1.83
Open price$1.83
Volume544.86K
Volume544.86K
52 Week high$3.10
52 Week high$3.10
52 Week low$1.32
52 Week low$1.32
Stock Snapshot
The current Protalix BioTherapeutics(PLX) stock price is $1.85, with a market capitalization of 146.35M. The stock trades at a price-to-earnings (P/E) ratio of 25.76.
On 2025-12-14, Protalix BioTherapeutics(PLX) stock moved within a range of $1.77 to $1.86. With shares now at $1.85, the stock is trading +4.7% above its intraday low and -0.6% below the session's peak.
Trading activity shows a volume of 544.86K, compared to an average daily volume of 534.99K.
The stock's 52-week range extends from a low of $1.32 to a high of $3.10.
The stock's 52-week range extends from a low of $1.32 to a high of $3.10.
People also own
Based on the portfolios of people who own PLX. This list is generated using Robinhood data, and it’s not a recommendation.